This is a preprint.
Comparative study on the virulence of mycobacteriophages
- PMID: 39554140
- PMCID: PMC11565895
- DOI: 10.1101/2024.10.23.619922
Comparative study on the virulence of mycobacteriophages
Update in
-
Comparative study on the virulence of mycobacteriophages.J Virol. 2025 Jun 17;99(6):e0192024. doi: 10.1128/jvi.01920-24. Epub 2025 May 21. J Virol. 2025. PMID: 40396760 Free PMC article.
Abstract
The global tuberculosis (TB) epidemic affected 10 million people and caused 1.3 million deaths in 2022 alone. Multidrug-resistant TB is successfully treated in less than 60% of cases by long, expensive and aggressive treatments. Mycobacteriophages, viruses that can infect bacteria such as Mycobacterium tuberculosis-the species responsible for TB, have the potential to redefine TB prevention and treatments. However, the development of phage-based products necessitates the assessment of numerous parameters, including virulence and adsorption, to ensure their performance and quality. In this work, we characterized the virulence of three different mycobacteriophages (Fionnbharth, Muddy and D29), alone and as cocktails, against a TB model host (Mycobacterium smegmatis) under planktonic and early-stage biofilm growth conditions. Phage D29 and cocktails containing D29 had the highest virulence under all conditions. Interestingly, phages Fionnbharth and Muddy and their combination showed higher virulence against early-stage biofilm than against the planktonic phenotype. Adsorption assays indicated that all three phages had lower adsorption efficiencies on the early-stage biofilm phenotype than on the planktonic one, suggesting a reduced availability of receptors in the former. Given that, despite these lower adsorption efficiencies, the virulence of the phages and phage cocktails was either unchanged or higher against the early-stage biofilm, this phenotype must display properties that are favorable to other steps of the infection process. These results inform us on the dynamics of mycobacteriophage infections, alone and in cocktail formulations, under different host growth conditions, and serve as a basis for the development of phage products targeting mycobacteria biofilms.
Keywords: Bacteriophages; D29; Fionnbharth; Muddy; Mycobacterium smegmatis; infection dynamics; mycobacteriophages; phage adsorption; phages; virulence; virulence index.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing interest.
Figures




References
-
- WHO. Global Tuberculosis Report 2023. (2023).
-
- Madhav B., Iyer A. & Jayalakshmi T. K. Side effect profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis. Eur. Respir. J. 46, (2015).
-
- Andersen P. & Scriba T. J. Moving tuberculosis vaccines from theory to practice. Nat. Rev. Immunol. 19, 550–562 (2019). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources